TUESDAY, Oct. 29, 2024 — For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations…Original Article
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
TUESDAY, Oct. 29, 2024 — For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations…
